soul trial semaglutide SOUL: Oral Cuts CV Events in Diabetic Patients Oral Semaglutide in High-Risk Type

In the SURMOUNT-1 trial, tirzepatide at 15 mg weekly resulted in up to 22.5% body weight reduction over 72 weeks (Jastreboff et al., 2022)

Change in Body Weight (%) from Baseline to Week 68 (Study 2) with WEGOVY Injection Observed data from in-trial period including imputed data for missing observations (RD-MI)

When appetite is low on a GLP-1, and your diet may look different than usual, a multivitamin can help fill in the gaps to ensure youre getting in all your essentials. How do you know if you need a multivitamin

The STEP 4 trial showed that participants who discontinued semaglutide after 20 weeks regained approximately two-thirds of the weight they had lost within the following year

If you start to notice more side effects, or if you feel best at the dose youre on, you dont have to titrate up to the maximum dose of 0.4mg, or 16 units

Wir gehen davon aus, dass sich die zuknftige Verfgbarkeit von Semaglutid schrittweise verbessern wird, sodass immer mehr neue Patient/-innen auf die Therapie eingestellt werden knnen